Acupuncture or Self-Acupuncture in Managing Cancer-Related Fatigue in Women Who Have Received Chemotherapy for Stage I, Stage II, or Stage IIIA Breast Cancer
Anxiety Disorder, Breast Cancer, Depression
About this trial
This is an interventional supportive care trial for Anxiety Disorder focused on measuring anxiety disorder, depression, fatigue, stage IA breast cancer, stage IB breast cancer, stage II breast cancer, stage IIIA breast cancer
Eligibility Criteria
DISEASE CHARACTERISTICS:
Diagnosis of breast cancer
- Stage I, II, or IIIA disease
Completed prior chemotherapy for ≥ 1 month and up to 5 years
- No needling on the ipsilateral arm of patients who have undergone axillary dissection
- No needling on the lymphedematous limbs
- Score of ≥ 5 on a 0-10 single-item screening fatigue scale, where 0 is no fatigue at all and 10 is extremely fatigued
- Hormone receptor status not specified
PATIENT CHARACTERISTICS:
- Life expectancy ≥ 6 months
- Menopausal status not specified
- Platelet count ≥ 50,000/mm^3
- Hemoglobin ≥ 10 g/dL
- Hematocrit ≥ 30%
- Not pregnant
- No needle phobia
No co-morbidity with any of the following:
- Bleeding disorder
- Thyroid dysfunction
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No planned concurrent chemoradiotherapy
- No concurrent steroids
- No concurrent epoetin alfa or transfusion for anemia
- No other concurrent complementary therapies
Sites / Locations
- University of Manchester
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Experimental
No Intervention
Experimental
No Intervention
Experimental
Arm I
Arm II
Arm A
Arm B
Arm C
Patients undergo a 20-minute acupuncture session once a week for 6 weeks. Patients also receive written information about fatigue and its possible management.
Patients receive standard care. They also receive written information about fatigue as in arm I.
Patients receive treatment as in arm I for 4 more weeks.
Patients receive standard care as in arm II for 4 more weeks.
Patients learn to self-acupuncture and do so weekly for 4 more weeks.